Phototherapy in the treatment of atopic dermatitis. Is monotherapy possible?
https://doi.org/10.51793/OS.2024.27.10.009
Abstract
Background. Currently, in the treatment of atopic dermatitis universally recognized phototherapy narrowband ultraviolet B (narrow-wave UVB therapy) with a maximum emission at a wavelength of 311 nm, the effectiveness of which has been confirmed by numerous studies. Phototherapy occupies the second line of therapy after unsuccessful treatment with emollients and topical glucocorticosteroids, it can be used both in mono and combined therapy. In addition, there is steroidophobia among patients, often the dermatologist is approached by patients who refuse not only systemic therapy, but also topical application of glucocorticosteroids, but readily agree to physical therapy, paying attention to the overall safety of phototherapy UVB-311 nm.
Results. The article presents the results of clinical studies of the effectiveness of narrow-band phototherapy UVB-311 nm in patients with atopic dermatitis in the form of monotherapy in combination with emollients. UVB-311 nm phototherapy is an effective method for treatment many skin diseases, however, there are still no clear recommendations on the use of the method depending on the severity and duration of the process. The authors, based on their own observations, concluded that monotherapy with narrow-band phototherapy UVB-311 nm is highly effective in patients with atopic dermatitis with a SCORAD index of no more than 40 points; in more severe cases, it is impossible to achieve a positive therapeutic effect with monotherapy. The authors demonstrated clinical cases from their own practice of using narrow-band phototherapy UVB-311 in patients with atopic dermatitis as monotherapy.
About the Authors
Yu. A. Gallyamova
Penza Institute of Advanced Medical Training
Russian Federation
Russian Federation
Yulia A. Gallyamova, Dr. of Sci. (Med.), Professor
8a Stasova str., Penza, 440069
A. R. Khasanova
Medsi Group of Companies
Russian Federation
Russian Federation
Alina R. Khasanova, Cand. of Sci. (Med.)
3A Gruzinsky Lane, Moscow, 123056
References
1. Garritsen F. M. Photo(chemo)therapy in the management of atopic dermatitis: An updated systematic review with implications for practice and research. Br J Dermatol. 2014; 170 (3): 501-513. DOI: 10.1111/bjd.12645.
2. Nexman P. N. Clinical Studie’s of Besnier’s Prurigo: Dissertation. Copenhagen: Rosenkide and Bagger, 1948.
3. Legat F. J. The antipuritic effect of phototherapy. Front Med. 2018; 30 (5): 333. DOI: 10.3389/fmed.2018.00333.
4. Gambichler T. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Br. J. Dermatol. 2009; 160 (3): 652-658. DOI: 10.1111/j.1365-2133.2008.08984.x.
5. Dotterud L. K. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthycontrols. Int. J. Circumpolar. Health. 2008; 67 (2-3): 254-260. DOI: 10.3402/ijch.v67i2-3.18282.
6. Hong S. P. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides andpermeability barrier reinforcement. J. Invest Dermatol. 2008; 128 (12): 2880-2887. DOI: 10.1038/jid.2008.169.
7. Borgia F., Li Pomi F., Vaccaro M., Alessandrello C., Papa V., Gangemi S. Oxidative Stress and Phototherapy in Atopic Dermatitis: Mechanisms, Role, and Future Perspectives. Biomolecules. 2022; 12 (12): 1904. DOI: 10.3390/biom12121904.
8. Bogadelnikova A. E. The influence of selective phototherapy of a narrow spectrum of 311 nm on some indicators of immune status in patients with atopic dermatitis. Vrach. 2007; (2): 63-64. (In Russ.)
9. Monakhov S. A., Korchazhkina N. B., Olisova O. Y. Narrow-band 311 nm phototherapy of patients with atopic dermatitis. Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei. 2012; (3): 25-27. (In Russ.)
10. Sidbury R., Davis D. M., Cohen D. E. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014; 71 (2): 327-349. DOI: 10.1016/j.jaad.2014.03.030.
11. Kubanov A. A., Abramova T. V., Murakhovskaya E. K. Methods of phototherapy in the treatment of dermatoses. Фарматека. 2017; 1-17: 12-17.
12. Kosheleva I. V., Khasanova A. R. Contemporary therapeutic approaches to atopic dermatitis: role of the phototherapy and searching for new possibilities. Lechaschi Vrach. 2018; (4): 24-26. (In Russ.)
13. Darrigade A. S. Traitements topiques et photothérapie dans la dermatite atopique. Ann Dermatol Venerol. 2019; 146 (12S3): 12S85-12S95. DOI: 10.1016/S0151-9638(20)30018-1.
14. Nicholas-Haizelden K., Murphy B., Michael Hoptroff M. Bioprospecting the Skin Microbiome: Advances in Therapeutics and Personal Care Product. Microorganisms. 2023; 11 (8): 1899. DOI: 10.3390/microorganisms11081899.
15. Wollenberg A., Barbarot S., Bieber T., Christen-Zaech S., Deleuran M. European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32 (5): 657-682. DOI: 10.1111/jdv.14891. Erratum in: J Eur Acad Dermatol Venereol. 2019; 33 (7): 1436. PMID: 29676534.
Review
For citations:
Gallyamova Yu.A., Khasanova A.R. Phototherapy in the treatment of atopic dermatitis. Is monotherapy possible? Lechaschi Vrach. 2024;(10):62-65. (In Russ.) https://doi.org/10.51793/OS.2024.27.10.009
Views:
222
JATS XML
Email this article 
